Pediatric Transplantation

Papers
(The H4-Index of Pediatric Transplantation is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
SARS‐CoV‐2 NAT+ donors for pediatric solid organ transplant recipients—Are they safe and provide good outcomes?62
Delayed‐Onset Renal Allograft Compartment Syndrome in a Pediatric Kidney Transplant Recipient: The Role of Surgical Re‐Evaluation28
Outcomes of pediatric deceased donor kidney transplant in northeast Thailand25
Successful use of intra‐operative continuous renal replacement therapy in pediatric liver transplant recipients: Single center case series22
The power of “it will be okay”21
Exploring the ethical complexity of pediatric organ transplant candidates and COVID‐19 vaccination: Tensions between autonomy and beneficence, children and parents21
Long‐term outcome of pediatric renal transplantation with donors younger than 6 years20
Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?17
Do vasoactive medications impact donor hearts clinical outcomes in pediatric heart transplantation?16
Pediatric‐Deceased Donor Livers in Mexico: How Current Policy Disadvantages Children16
Long‐term outcomes of two‐dose alemtuzumab induction in pediatric kidney transplantation16
Bortezomib as a Potential Treatment for Recurrent Autoimmune Hepatitis Following Pediatric Liver Transplantation16
Haploidentical Hematopoietic Cell Transplantation With Post‐Transplant Cyclophosphamide for Pediatric Chronic Active Epstein–Barr Virus Infection15
The Impact of Early Indication of Living Donor Liver Transplantation on the Outcomes of Patients With Propionic Acidemia: A Single‐Center Experience15
Prevalence and spectrum of infectious and inflammatory dermatologic conditions occurring in pediatric heart transplant patients on a predominantly mTOR‐based immune suppressive regimen: A retrospectiv14
0.13493490219116